Financial reports
10-Q
2013 Q2
Quarterly report
13 Aug 13
10-Q
2013 Q1
Quarterly report
13 May 13
10-K
2012 FY
Annual report
8 Mar 13
10-Q
2012 Q3
Quarterly report
13 Nov 12
10-Q
2012 Q2
Quarterly report
13 Aug 12
10-Q
2012 Q1
Quarterly report
14 May 12
10-K
2011 FY
Annual report
6 Mar 12
10-Q
2011 Q3
Quarterly report
10 Nov 11
10-Q
2011 Q2
Quarterly report
11 Aug 11
10-Q
2011 Q1
Quarterly report
12 May 11
Current reports
8-K
Entry into a Material Definitive Agreement
4 Nov 13
8-K
Submission of Matters to a Vote of Security Holders
22 Oct 13
8-K
Other Events
7 Oct 13
8-K
Theragenics Corporation Reports Second Quarter 2013 Results
8 Aug 13
8-K
Entry into a Material Definitive Agreement
7 Aug 13
8-K
Other Events
13 Jun 13
8-K
Submission of Matters to a Vote of Security Holders
21 May 13
8-K
Theragenics Corporation Receives Proposal to Acquire all Outstanding Common Stock at $2.25 to $2.30 Per Share
13 May 13
8-K
Theragenics Corporation Reports First Quarter 2013 Results
9 May 13
8-K
Departure of Directors or Certain Officers
27 Feb 13
Registration and prospectus
15-12G
Securities registration termination
12 Nov 13
S-8 POS
Registration of securities for employees (post-effective amendment)
6 Nov 13
S-8 POS
Registration of securities for employees (post-effective amendment)
6 Nov 13
S-8 POS
Registration of securities for employees (post-effective amendment)
6 Nov 13
S-8 POS
Registration of securities for employees (post-effective amendment)
6 Nov 13
S-8 POS
Registration of securities for employees (post-effective amendment)
6 Nov 13
S-8 POS
Registration of securities for employees (post-effective amendment)
6 Nov 13
POS AM
Prospectus update (post-effective amendment)
31 Oct 13
POS AM
Prospectus update (post-effective amendment)
31 Oct 13
25-NSE
Exchange delisting
30 Oct 13
Proxies
DEFA14A
Additional proxy soliciting materials
7 Oct 13
DEFM14A
Proxy related to merger
17 Sep 13
DEFA14A
Additional proxy soliciting materials
9 Sep 13
PREM14A
Preliminary proxy related to merger
23 Aug 13
DEFA14A
Additional proxy soliciting materials
13 Aug 13
DEFA14A
Additional proxy soliciting materials
8 Aug 13
DEFA14A
Additional proxy soliciting materials
7 Aug 13
DEFA14A
Additional proxy soliciting materials
5 Aug 13
DEF 14A
Definitive proxy
1 Apr 13
DEF 14A
Definitive proxy
4 Apr 12
Other
EFFECT
Notice of effectiveness
5 Nov 13
EFFECT
Notice of effectiveness
5 Nov 13
CT ORDER
Confidential treatment order
26 Jul 12
UPLOAD
Letter from SEC
30 Jul 09
CORRESP
Correspondence with SEC
22 Jul 09
UPLOAD
Letter from SEC
9 Jul 09
CORRESP
Correspondence with SEC
25 Jun 09
UPLOAD
Letter from SEC
29 May 09
EFFECT
Notice of effectiveness
27 Jun 07
EFFECT
Notice of effectiveness
17 Oct 06
Ownership
SC 13G/A
Theragenics Corp
13 Feb 14
SC 13G/A
Theragenics Corp
10 Feb 14
SC 13D
Theragenics Corp
12 Aug 13
SC 13D
Theragenics Corp
12 Aug 13
SC 13D/A
Theragenics Corp
5 Aug 13
SC 13D/A
Theragenics Corp
13 Jun 13
SC 13D/A
MICHAS ALEXIS P
13 May 13
SC 13D/A
MICHAS ALEXIS P
18 Jul 12
SC 13D
MICHAS ALEXIS P
5 Mar 12